Search Results 831-840 of 17099 for monoclonal antibody

1. Dasatinib And Quercetin With CAR T Therapy For The Treatment Of Patients With Relapsed Or Refractory Multiple Myeloma - Mayo Clinic

   ... monoclonal antibody (mAb) * Ciltacabtagene autoleucel (Carvykti) available ... * Monoclonal gammopathy of undetermined significance, smoldering multiple myeloma, ...

2. ALPN-202 With PD-1 Inhibition in Advanced Malignancies - Mayo Clinic

   Other monoclonal antibodies, antibody-drug conjugates, bispecific antibodies, antibody-like drugs, cytokines, cell therapies, or radioimmunoconjugates: 4 weeks.

3. Safety and Efficacy of SA4Ag Vaccine in Adults Having Elective Open Posterior Spinal Fusion Procedures With Multilevel Instrumentation - Mayo Clinic

   ... monoclonal antibodies) prior to the index hospital admission. Previous administration of S aureus vaccine or S aureus/Candida vaccine. Antibiotic therapy ...

4. Overview - Transplant Immunology Program - Mayo Clinic Research

   The Transplant Immunology Program at Mayo Clinic is overcoming antibody-related organ rejection, improving long-term outcomes and forging key partnerships.

5. Pemigatinib to Treat Metastatic or Unresectable Colorectal Cancer Harboring FGFR Alterations - Mayo Clinic

   ... monoclonal antibody, if eligible for this therapy;. Anti-EGFR (epidermal growth factor receptor) monoclonal antibody, if eligible for this therapy.

6. Herd immunity, antibodies & COVID-19 / bile duct cancer / peripheral artery disease - Mayo Clinic News Network

   Herd immunity, antibodies & COVID-19 / bile duct cancer / peripheral artery disease. Aug. 1, 2020. Related Episodes.

7. Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ANX005 in Subjects With Warm Autoimmune Hemolytic Anemia (wAIHA) - Mayo Clinic

   - History of splenectomy within the 3 months prior to screening. - Received rituximab or other anti-CD20 monoclonal antibody <3 months prior to screening ...

8. A Study of HFB200301 in Adult Patients With Advanced Solid Tumors - Mayo Clinic

   monoclonal antibodies or any excipient of HFB200301 - Using sensitive substrates of major cytochrome P450 (CYP450) enzymes - Known active malignancy, with ...

9. A Study to Assess the Adverse Events and Change in Disease Activity in Adult Participants With Relapsed or Refractory Multiple Myeloma Receiving Oral ABBV-453 Tablets - Mayo Clinic

   therapy, including a proteasome inhibitors (PI), an Immunomodulatory drugs (IMID), and an anti-CD38 monoclonal antibody. - Permitted to be venetoclax or BCL ...

10. A Phase 2/3 Study of Indoximod or Placebo Plus Pembrolizumab or Nivolumab in Subjects With Unresectable or Metastatic Melanoma - Mayo Clinic

    Has received prior adjuvant therapy, monoclonal antibody or an investigational agent or device within 4 weeks or 5 half-lives (whichever is longer); Has ...